Bangladesh vs Europe (WHO region): New cases tested for RR-/MDR-TB
Bangladesh
100.0%
in 2024
Europe (WHO region)
88.0%
in 2024
Bangladesh rank
1st
Europe (WHO region) rank
3rd
New cases tested for RR-/MDR-TB over time
- Bangladesh
- Europe (WHO region)
How they compare
Bangladesh currently reports 100.0% against 88.0% in Europe (WHO region), a difference of 12.0%.
That makes Bangladesh's figure about 1.1 times Europe (WHO region)'s.
The two have swapped places 1 time across 14 shared years of data; in 2011 it was Europe (WHO region) ahead.
Bangladesh ranks 1st and Europe (WHO region) ranks 3rd of 192 countries.
Europe (WHO region) has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Bangladesh | Europe (WHO region) | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 14.2% | 86.7% | 72.4% | Europe (WHO region) |
| 2020s | 56.2% | 90.8% | 34.6% | Europe (WHO region) |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, Bangladesh or Europe (WHO region)?
- Bangladesh, at 100.0% against 88.0% in Europe (WHO region) as of 2024.
- What is the difference in new cases tested for rr-/mdr-tb between Bangladesh and Europe (WHO region)?
- 12.0%, with Bangladesh ahead.
- How many years of comparable data are there for Bangladesh and Europe (WHO region)?
- 14 years are reported by both, from 2011 to 2024.
- How do Bangladesh and Europe (WHO region) rank globally for new cases tested for rr-/mdr-tb?
- Bangladesh ranks 1st and Europe (WHO region) ranks 3rd of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.